Daesung Microbiological Labs. Co., Ltd. (KOSDAQ: 036480)

Daesung Microbiological Labs. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,684	4,362	3,852	4,395	5,212	8,252
Short-Term Investments	5,519	7,365	9,007	5,539	4,840	4,252
Cash & Short-Term Investments	8,203	11,727	12,859	9,935	10,052	12,504
Cash Growth	-39.18%	-8.80%	29.44%	-1.17%	-19.61%	11.90%
Accounts Receivable	3,431	4,131	3,040	2,986	3,675	2,867
Other Receivables	213.25	154.12	155.37	71.96	54.86	103.4
Receivables	3,644	4,285	3,196	3,058	3,730	2,970
Inventory	12,650	12,499	11,641	10,614	9,197	9,266
Prepaid Expenses	98.48	171.07	35.26	32.9	615.23	298.54
Other Current Assets	10.53	34.1	958.97	82.36	163.6	0.64
Total Current Assets	24,605	28,717	28,690	23,722	23,757	25,039
Property, Plant & Equipment	31,428	32,124	33,303	35,846	35,285	23,147
Long-Term Investments	1,405	1,498	1,256	1,327	1,346	950.37
Other Intangible Assets	355.95	356.77	354.83	356.3	358	359.6
Long-Term Deferred Tax Assets	692.15	734.47	134.47	355.46	374.75	463.51
Long-Term Deferred Charges	253.2	330.08	518.86	717.28	846.22	772.46
Other Long-Term Assets	608.38	530.37	852.47	295.71	295.71	295.71
Total Assets	59,348	64,290	65,109	62,620	62,263	51,028
Accounts Payable	1,620	1,543	977.94	768.84	1,237	1,813
Accrued Expenses	873.25	711.53	2,641	2,047	2,180	1,150
Short-Term Debt	3,000	5,319	2,000	700	877.56	700
Current Portion of Long-Term Debt	3,150	2,125	4,350	1,500	-	-
Current Portion of Leases	93.37	152.28	140.83	175.61	172.18	-
Current Income Taxes Payable	-	-	377.59	-	-	-
Other Current Liabilities	376.94	547.67	124.03	122.82	111.31	106.38
Total Current Liabilities	9,114	10,398	10,611	5,315	4,578	3,769
Long-Term Debt	14,350	16,375	15,500	19,850	20,550	10,500
Long-Term Leases	122.21	40.36	38.45	126.51	302.12	643.11
Other Long-Term Liabilities	127.98	127.98	122.51	130.67	-0	-0
Total Liabilities	23,714	26,942	26,272	25,616	25,952	16,312
Common Stock	1,900	1,900	1,900	1,900	1,900	1,900
Additional Paid-In Capital	3,085	3,085	3,085	3,085	3,085	3,085
Retained Earnings	27,489	29,204	30,693	28,859	28,167	26,571
Comprensive Income & Other	3,160	3,160	3,160	3,160	3,160	3,160
Shareholders' Equity	35,634	37,349	38,837	37,004	36,311	34,715
Total Liabilities & Equity	59,348	64,290	65,109	62,620	62,263	51,028
Total Debt	20,716	24,011	22,029	22,352	21,902	11,843
Net Cash (Debt)	-12,513	-12,284	-9,170	-12,418	-11,850	660.84
Net Cash Growth	-	-	-	-	-	-93.61%
Net Cash Per Share	-3289.94	-3232.58	-2412.16	-3255.27	-3121.22	173.83
Filing Date Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Total Common Shares Outstanding	3.8	3.8	3.8	3.8	3.8	3.8
Working Capital	15,491	18,319	18,079	18,407	19,179	21,270
Book Value Per Share	9377.39	9828.59	10220.37	9737.79	9555.62	9135.63
Tangible Book Value	35,278	36,992	38,483	36,647	35,953	34,356
Tangible Book Value Per Share	9283.71	9734.70	10127.00	9644.03	9461.40	9041.00
Land	2,982	2,982	2,982	5,335	5,335	5,335
Buildings	16,311	16,596	17,167	17,741	17,791	5,803
Machinery	11,325	9,449	10,679	10,440	11,114	1,049
Construction In Progress	593.85	2,909	2,302	2,038	580.63	10,324

Source: S&P Capital IQ. Standard template. Financial Sources.